EF
MRVI icon

Empowered Funds’s Maravai LifeSciences MRVI Stock Holding History

Empowered Funds’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$255K Sell
90,161
-5,173
-5% -$17.5K ﹤0.01% 1902
2025
Q4 		$310K Buy
95,334
+2,019
+2% +$6.8K 0.01% 846
2025
Q3 		$268K Buy
93,315
+3,271
+4% +$8.35K ﹤0.01% 1631
2025
Q2 		$217K Buy
90,044
+58,016
+181% +$122K ﹤0.01% 1619
2025
Q1 		$70.8K Buy
32,028
+3,672
+13% +$14.5K ﹤0.01% 1597
2024
Q4 		$155K Buy
+28,356
New +$182K ﹤0.01% 1537

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Empowered Funds's MRVI Position: Q1 2026 in Review

Empowered Funds reduced its Maravai LifeSciences (MRVI) stake by 5.4% in Q1 2026, selling an estimated $17.5K and leaving 90,161 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

Empowered Funds first reported a position in MRVI in Q4 2024 and has held it in 6 quarters since. The position peaked at $310K in Q4 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Empowered Funds held 90,161 shares of Maravai LifeSciences worth $255K as of Q1 2026.
  • Empowered Funds sold 5,173 Maravai LifeSciences shares in Q1 2026, an estimated $17.5K.
  • Maravai LifeSciences made up ﹤0.01% of Empowered Funds's portfolio in Q1 2026, its #1902 holding.
  • Empowered Funds first reported a position in Maravai LifeSciences in Q4 2024 and has held it in 6 quarters since.
  • Empowered Funds's Maravai LifeSciences position peaked at $310K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.